Mirtazapine-induced hyponatraemia

Medical Journal of Australia

Volumn 179, Issue 8, 2003, Pages 453-454

  Roxanas, Milton G ^a  

^a Epping Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMIODARONE; ATORVASTATIN; DIURETIC AGENT; GLICLAZIDE; GLUCOSE; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; MIANSERIN; MIRTAZAPINE; OMEPRAZOLE; SODIUM; THYROXINE; VENLAFAXINE; ZOLPIDEM;

AGED; AUSTRALIA; CASE REPORT; DEPRESSION; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; GENDER; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPONATREMIA; LABORATORY TEST; LETTER; PRESCRIPTION; RISK FACTOR; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; URINE OSMOLALITY;

EID: 0142198870     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05635.x     Document Type: Letter

References (4)

1. Helderman JH, Vestal RE, Rowe JW, et al. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: The impact of aging. J Gerontology 1978; 33: 39-47.
2. Kirby D, Ames D. Hyponatraemia and selective serotonin reuptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001; 16: 484-493.
3. Spigset O, Hedenmalm K. Hyponatraemia in relation to treatment with antidepressants: A survey of reports in the WHO database for spontaneous reporting of adverse drug reactions. Pharmacotherapy 1997; 17: 348-352.
4. Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: A retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 2002; 17: 231-237.